US 11,717,601 B2
Dialysis systems, devices, and methods
Jeffrey H. Burbank, Manchester, MA (US); James M. Brugger, Newburyport, MA (US); Dennis M. Treu, Castle Rock, CO (US); and Mark T. Wyeth, Andover, MA (US)
Assigned to NxStage Medical, Inc., Lawrence, MA (US)
Filed by NxStage Medical, Inc., Lawrence, MA (US)
Filed on Aug. 26, 2021, as Appl. No. 17/412,846.
Application 17/412,846 is a continuation of application No. 16/360,396, filed on Mar. 21, 2019.
Application 16/360,396 is a continuation of application No. 15/476,927, filed on Mar. 31, 2017, granted, now 10,688,235, issued on Jun. 23, 2020.
Application 15/476,927 is a continuation of application No. 15/400,978, filed on Jan. 7, 2017, granted, now 10,046,100, issued on Aug. 14, 2018.
Application 15/400,978 is a continuation of application No. 14/006,763, granted, now 9,907,897, issued on Mar. 6, 2018, previously published as PCT/US2012/030350, filed on Mar. 23, 2012.
Claims priority of provisional application 61/509,240, filed on Jul. 19, 2011.
Claims priority of provisional application 61/490,183, filed on May 26, 2011.
Claims priority of provisional application 61/466,921, filed on Mar. 23, 2011.
Prior Publication US 2021/0386923 A1, Dec. 16, 2021
Int. Cl. A61M 1/28 (2006.01); A61M 1/16 (2006.01); A61M 25/00 (2006.01)
CPC A61M 1/282 (2014.02) [A61M 1/166 (2014.02); A61M 1/167 (2014.02); A61M 1/1656 (2013.01); A61M 1/1664 (2014.02); A61M 1/1668 (2014.02); A61M 1/1672 (2014.02); A61M 1/1674 (2014.02); A61M 1/28 (2013.01); A61M 1/281 (2014.02); A61M 1/285 (2013.01); A61M 1/287 (2013.01); A61M 1/288 (2014.02); A61M 2025/0002 (2013.01); A61M 2205/12 (2013.01); A61M 2205/123 (2013.01); A61M 2205/128 (2013.01); A61M 2205/14 (2013.01); A61M 2205/18 (2013.01); A61M 2205/33 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3351 (2013.01); A61M 2205/3355 (2013.01); A61M 2205/52 (2013.01); A61M 2230/005 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A medical treatment system, comprising:
a treatment device for performing a therapy on a patient and configured to prepare a therapeutic fluid used in the therapy from at least one concentrate and from purified water, the treatment device configured to receive a disposable cartridge that holds at least a portion of a tubing set, the treatment device being further configured to convey fluid through the tubing set;
a water purification device in fluid communication with and providing the purified water to the treatment device;
a controller configured to cause production of the therapeutic fluid by mixing the purified water and the at least one concentrate; and
a user interface operably connected to the controller, the user interface configured to receive operator inputs, wherein
the controller controls operation of the treatment device and the water purification device,
and wherein the water purification device is configured to initiate transmission of at least one of state information, component life information, and alert information about the water purification device to the user interface, and the user interface displays the transmitted at least one of state information, component life information, and alert information.